Feasibility of Using Autologous Transplantation to Evaluate Hematopoietic Stem Cell-Based Gene Therapy Strategies in Transgenic Mouse Models of Human Disease

Author： Miller C.L.   Imren S.   Antonchuk J.   Kalberer C.   Fabry M.E.   Nagel R.L.   Humphries R.K.   Eaves C.J.  

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.6, Iss.3, 2002-09, pp. : 422-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic Modulation: A Promising Avenue to Advance Hematopoietic Stem Cell-Based Therapy for Severe Autoimmune Disorders

By  

Epigenetic Diagnosis & Therapy, Vol. 1, Iss. 2, 2016-03 ,pp. : 120-127

Bentham Science Publishers

Access to resources Recommend Favorite

Acute graft‐versus‐host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma

By  

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 370-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of niemann-pick disease

By Jin H.-K.   Schuchman E.H.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 876-885

Elsevier

Access to resources Recommend Favorite

Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus‐Merzbacher disease

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 8, 2015-08 ,pp. : 787-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transient Efficacy of Double High-Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation, Immunoglobulin, Thalidomide, and Bortezomib in the Treatment of Scleromyxedema

By Ataergin Selmin  

American Journal of Clinical Dermatology, Vol. 9, Iss. 4, 2008-01 ,pp. : 271-273

Adis International

Access to resources Recommend Favorite